Compare Natera Inc. Common Stock (NTRA) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Vanguard Total International Stock Index Fund ETF — how do they compare? Natera Inc. Common Stock trades at $394.6 (market cap $57.03B), while Vanguard Total International Stock Index Fund ETF trades at $83.19 (market cap $665.70B). The key difference: Vanguard Total International Stock Index Fund ETF is far larger — about 11.7× Natera Inc. Common Stock's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Vanguard Total International Stock Index Fund ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Vanguard Total International Stock Index Fund ETF for 56 Days on average.
| NTRA | VXUS | |
|---|---|---|
Market Cap | $57.03B | $665.70B |
Volume | 1,131,157 | 4,659,186 |
Sector | Health | Sector/Thematic |
52-Week High | $425.64 | $88.41 |
52-Week Low | $179.42 | $72.19 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
VXUS trades at $84.54 with minimal daily movement (+0.12%). Technical indicators show bearish momentum with moving averages signaling sell pressure, while oscillators remain neutral. The ETF provides broad international stock exposure outside the U.S., offering diversification benefits. Recent institutional activity shows growing interest, with firms like QRG Capital increasing positions by 97.8% in Q2 2026 (SEC filing, September 2026).
VXUS offers cost-effective international diversification but faces currency and geopolitical risks. Current bearish technicals suggest near-term pressure, while long-term prospects depend on global market performance versus U.S. equities. The upcoming $0.16 dividend in September 2026 provides income, but foreign tax credit limitations in IRAs may reduce net returns for some investors (24/7 Wall Street, August 2026).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
